{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:49:22Z","timestamp":1791557362571,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.ejphar.2011.10.002","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T00:16:43Z","timestamp":1318810603000},"page":"121-125","source":"Crossref","is-referenced-by-count":23,"title":["Differences between mice strains in response to paroxetine in the forced swimming test: Involvement of serotonergic or noradrenergic systems"],"prefix":"10.1016","volume":"672","author":[{"given":"Yumi","family":"Sugimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiharu","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Mitsui-Saitoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.10.002_bb0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/026988110201600403","article-title":"Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study","volume":"16","author":"Beyer","year":"2002","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2011.10.002_bb0010","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0028-3908(91)90178-E","article-title":"Involvement of 5-HT1A receptors in the antidepressant-like activity of gepirone in the forced swimming test in rats","volume":"30","author":"Chojnacka-Wojcik","year":"1991","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2011.10.002_bb0015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00213-005-0166-5","article-title":"Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test","volume":"183","author":"Crowley","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2011.10.002_bb0020","first-page":"285","article-title":"On the role of noradrenergic neurotransmission in the action of desipramine and amitriptyline in animal models of depression","volume":"38","author":"Danysz","year":"1986","journal-title":"Pol. J. Pharmacol. Pharm."},{"key":"10.1016\/j.ejphar.2011.10.002_bb0025","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/sj.bjp.0705538","article-title":"Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice","volume":"140","author":"David","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.10.002_bb0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0166-4328(96)00067-8","article-title":"Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth","volume":"73","author":"Detke","year":"1996","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2011.10.002_bb0035","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainres.2009.06.035","article-title":"\u03b11\u0391- and \u03b11B-adrenergic receptors differentially modulate antidepressant-like behavior in the mouse","volume":"1285","author":"Doze","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2011.10.002_bb0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2008.07.031","article-title":"Strain differences in paroxetine-induced reduction of immobility time in the forced swimming test in mice: role of serotonin","volume":"594","author":"Guzzetti","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.10.002_bb0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2007.03.003","article-title":"Antidepressant-like effect of lamotrigine in the mouse forced swimming test: evidence for the involvement of the noradrenergic system","volume":"565","author":"Kaster","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.10.002_bb0050","first-page":"27","article-title":"The contribution of pre-clinical drug evaluation in predicting clinical profile of the selective serotonin reuptake inhibitor paroxetine","volume":"1","author":"Kelly","year":"1995","journal-title":"J. Ser. Res."},{"key":"10.1016\/j.ejphar.2011.10.002_bb0055","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.neuron.2007.07.041","article-title":"Serotonin(4)(5-HT4) receptor agonists are putative antidepressnts with a rapid onset of action","volume":"55","author":"Lucas","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2011.10.002_bb0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0006-3223(01)01145-3","article-title":"Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine","volume":"50","author":"Owens","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2011.10.002_bb0065","first-page":"327","article-title":"Behavioural despair in mice:a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn."},{"key":"10.1016\/j.ejphar.2011.10.002_bb0070","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0014-2999(79)90366-2","article-title":"Immobility induced by forced swimming in rats:Effects of agents which modify central catecholamine and serotonin activity","volume":"57","author":"Porsolt","year":"1979","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.10.002_bb0080","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-2999(97)00115-5","article-title":"Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test","volume":"325","author":"Redrobe","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.10.002_bb0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-2999(96)00772-8","article-title":"The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test","volume":"318","author":"Redrobe","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.10.002_bb0085","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/026988119801200404","article-title":"Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms","volume":"12","author":"Redrobe","year":"1998","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2011.10.002_bb0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0166-4328(03)00034-2","article-title":"Antidepressant-like effects in various mice strains in the tail suspension test","volume":"143","author":"Ripoll","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2011.10.002_bb0100","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1023\/A:1006986824213","article-title":"Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding","volume":"19","author":"Sanchez","year":"1999","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2011.10.002_bb0095","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s002130050181","article-title":"Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?","volume":"129","author":"Sanchez","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2011.10.002_bb0105","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0006-3223(99)00234-6","article-title":"Alfa-1-noradrenergic neurotransmission, corticosterone, and behavioral depression","volume":"46","author":"Stone","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2011.10.002_bb0110","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1248\/bpb.25.1479","article-title":"The 5-HT2 receptor antagonist reduces immobility of mice treated with the atypical antidepressant mianserin in the forced swimming test","volume":"25","author":"Sugimoto","year":"2002","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2011.10.002_bb0115","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejphar.2008.07.005","article-title":"Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test:Analysis of serotonin and noradrenaline transporter binding","volume":"592","author":"Sugimoto","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.10.002_bb0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejphar.2009.11.057","article-title":"Involvement of the 5-HT1A receptor in the anti-immobility effects of fluvoxamine in the forced swimming test and mouse strain differences in 5-HT1A receptor binding","volume":"629","author":"Sugimoto","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.10.002_bb0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejphar.2010.02.016","article-title":"Antidepressant-like effects of neferine in the forced swimming test involve the serotonin1A (5-HT1A) receptor in mice","volume":"634","author":"Sugimoto","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.10.002_bb0130","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/00001756-200305230-00032","article-title":"Caffeic acid produces antidepressive- and\/or anxiolytic-like effects through indirect modulation of the \u03b11A-adrenoceptor system in mice","volume":"14","author":"Takeda","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejphar.2011.10.002_bb0135","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2165\/00003495-200262040-00010","article-title":"Paroxetine: an update of its use in psychiatric disorders in adults","volume":"62","author":"Wagstaff","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2011.10.002_bb0140","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0014-2999(01)01240-7","article-title":"Effects of 5-HT2 receptor antagonists on the anti-immobility effects of imipramine in the forced swimming test with mice","volume":"427","author":"Yamada","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.10.002_bb0145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-8993(02)03684-3","article-title":"Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test","volume":"958","author":"Yamada","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2011.10.002_bb0150","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejphar.2004.09.057","article-title":"Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test","volume":"504","author":"Yamada","year":"2004","journal-title":"Eur. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911012039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911012039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T07:52:33Z","timestamp":1543477953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299911012039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":30,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0014299911012039"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.10.002","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}